Alteration of tyrosine aminotransferase multiple form patterns by antisickling agents and a decomposition product of antitumor agents.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000818:Animals; D002219:Carbamates / Q000378:metabolism; D002330:Carmustine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects; D002852:Chromatography, Ion Exchange; D003485:Cyanates / Q000378:metabolism / Q000494:pharmacology; D006207:Half-Life; D007527:Isoenzymes / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D051381:Rats; D013997:Time Factors; D014444:Tyrosine Transaminase / Q000378:metabolism*
D002219:Carbamates; D003485:Cyanates; D007527:Isoenzymes; D014444:Tyrosine Transaminase; D002330:Carmustine